Concepedia

Boris Bleijlevens

BB

Statistics

Publications

30

Citations

2.7K

H-Index

22

Active since

2001

Affiliations

University of Amsterdam(Current)

Amsterdam UMC Location University of Amsterdam

Imperial College London

Humboldt-Universität zu Berlin

Netherlands Institute for Neuroscience

Boris Bleijlevens is an author at University of Amsterdam specializing in life sciences, biochemistry, and enzymology.

Publications per year

2001–2021

30

Publications

30

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation

Laween Uthman, Antonius Baartscheer, Boris Bleijlevens et al. · Diabetologia · 2017 · 600 citations · Full text

Medicine, Cardiology, Pharmacology +16

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention

Rolf G. Boot, Marri Verhoek, Maaike de Fost et al. · Blood · 2003 · 338 citations · Full text

Life Sciences, Immunology, Pathology +15

Ultrasensitive in situ visualization of active glucocerebrosidase molecules

Martin D. Witte, Wouter W. Kallemeijn, Jan Aten et al. · Nature Chemical Biology · 2010 · 226 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +10

1001 Ways to run AutoDock Vina for virtual screening

Mohammad Mahdi Jaghoori, Boris Bleijlevens, Sílvia D. Olabarriaga · Journal of Computer-Aided Molecular Design · 2016 · 212 citations · Full text

Pharmacy, Bioinformatics, High-performance Computing +17

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis

Tom Seijkens, Claudia M. van Tiel, Pascal Kusters et al. · Journal of the American College of Cardiology · 2018 · 194 citations · Full text

Life Sciences, Immunology, Pathobiology +16

1–5 of 30